A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects

NCT07057726 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability in Healthy Volunteers

Interventions

DRUG: SSS39
DRUG: SSS39

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.